Emilia Fortunati

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Retraction notice to Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine [Seminars Nucl Med 55 (2025) 648-663].

Retraction notice to Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine [Seminars Nucl Med 55 (2025) 648-663].

Journal: Seminars in nuclear medicine

Published: January 17, 2026

Dynamic Total-Body PET Imaging Unfolds [11C]Choline Kinetics and Dosimetry in Primary Hyperparathyroidism.

Dynamic Total-Body PET Imaging Unfolds [11C]Choline Kinetics and Dosimetry in Primary Hyperparathyroidism.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 03, 2025

Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine.

Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine.

Journal: Seminars in nuclear medicine

Published: April 30, 2025

Risk of Thyroid Cancer in Children, Adolescents, and Young Adults with Hashimoto Thyroiditis: A 27-Year Follow-Up Study.

Risk of Thyroid Cancer in Children, Adolescents, and Young Adults with Hashimoto Thyroiditis: A 27-Year Follow-Up Study.

Journal: Hormone research in paediatrics

Published: April 07, 2025

Optimization and scale-up of [68Ga]Ga-FAPI-46 production on a Modular-Lab PharmTracer platform for clinical application.

Optimization and scale-up of [68Ga]Ga-FAPI-46 production on a Modular-Lab PharmTracer platform for clinical application.

Journal: Nuclear medicine and biology

Published: October 01, 2024

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial.

[68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 01, 2024

The role of combined FDG and SST PET/CT in neuroendocrine tumors.

The role of combined FDG and SST PET/CT in neuroendocrine tumors.

Journal: Journal of neuroendocrinology

Published: July 12, 2024

β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients.

β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients.

Journal: Journal of clinical medicine

Published: May 28, 2024

Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach.

Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach.

Journal: Heliyon

Published: April 08, 2024

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update.

Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update.

Journal: Current oncology reports

Published: March 26, 2024

State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms.

State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms.

Journal: Journal of computer assisted tomography

Published: March 22, 2024

Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients.

Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients.

Journal: Cancers

Published: December 29, 2023

Showing 1-12 of 20

Last Updated: 09/26/2026